Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease

Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease

Objective: Acute-onset diffuse interstitial lung disease (AoDILD) includes acute exacerbation of interstitial lung disease (ILD), drug-induced ILD, and Pneumocystis pneumonia, and frequently occurs in patients with rheumatoid arthritis (RA). Since AoDILD causes a poor prognosis in RA, biomarkers for...

Full description

Bibliographic Details
Main Authors:	Hiroshi Furukawa, Shomi Oka, Kota Shimada, Atsushi Hashimoto, Akiko Komiya, Toshihiro Matsui, Naoshi Fukui, Shigeto Tohma
Format:	Article
Language:	English
Published:	SAGE Publishing 2019-08-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.1177/1177271919870472

Similar Items

Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case–Control Study
by: Hiroshi Furukawa, et al.
Published: (2020-12-01)

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
by: Hiroshi Furukawa, et al.
Published: (2021-06-01)

Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases
by: Hiroshi Furukawa, et al.
Published: (2019-07-01)

Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease
by: Shomi Oka, et al.
Published: (2024-11-01)

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
by: Shomi Oka, et al.
Published: (2022-01-01)

Lack of Association of rs12702634 in With Interstitial Lung Diseases in Japanese Rheumatoid Arthritis Patients
by: Takashi Higuchi, et al.
Published: (2022-04-01)

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results
by: Shomi Oka, et al.
Published: (2022-03-01)

Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2014-01-01)

Antibodies against Serum Anti-Melanoma Differentiation-Associated Gene 5 in Rheumatoid Arthritis Patients with Chronic Lung Diseases
by: Shomi Oka, et al.
Published: (2023-02-01)

HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2014-05-01)

Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope.
by: Hiroshi Furukawa, et al.
Published: (2012-01-01)

Genetics of Interstitial Lung Disease: (Night Flight)
by: Hiroshi Furukawa, et al.
Published: (2015-01-01)

Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight)
by: Hiroshi Furukawa, et al.
Published: (2015-04-01)

Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis
by: Hiroshi Furukawa, et al.
Published: (2023-01-01)

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations.
by: Hiroshi Furukawa, et al.
Published: (2018-01-01)

Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease
by: Shomi Oka, et al.
Published: (2022-06-01)

Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics
by: Shinichi Nogi, et al.
Published: (2018-01-01)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
by: Hiroshi Furukawa, et al.
Published: (2015-08-01)

A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition
by: Naoto Yokogawa, et al.
Published: (2020-05-01)

Associations of <i>HLA</i> Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
by: Takashi Higuchi, et al.
Published: (2023-02-01)

Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients.
by: Hiroshi Furukawa, et al.
Published: (2013-01-01)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2022-08-01)

Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01
by: Hiroshi Furukawa, et al.
Published: (2024-02-01)

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study
by: Takahiro Nishino, et al.
Published: (2023-03-01)

The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica
by: Takashi Higuchi, et al.
Published: (2024-01-01)

Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response
by: Takashi Higuchi, et al.
Published: (2021-01-01)

Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis
by: Hiroaki Mori, et al.
Published: (2019-01-01)

A proteomic analysis of serum-derived exosomes in rheumatoid arthritis
by: Hirotaka Tsuno, et al.
Published: (2018-11-01)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)

Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
by: Hiroshi Furukawa, et al.
Published: (2016-01-01)

Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
by: Hiroshi Furukawa, et al.
Published: (2014-01-01)

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan
by: Hiroshi Furukawa, et al.
Published: (2022-04-01)

Joint index vector: a novel assessment measure for stratified medicine in patients with rheumatoid arthritis
by: Susumu Nishiyama, et al.
Published: (2018-10-01)

INTERSTITIAL LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS
by: David Vladimirovich Bestaev, et al.
Published: (2012-12-01)

Interstitial lung involvement in rheumatoid arthritis
by: David Vladimirovich Bestaev, et al.
Published: (2014-12-01)

Interstitial lung disease in rheumatoid arthritis
by: Laura Groseanu
Published: (2023-12-01)

Emphysema and Interstitial Pneumonia in Rheumatoid Arthritis
by: Fumikazu Sakai
Published: (2018-02-01)

Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients
by: Shota Kurushima, et al.
Published: (2024-12-01)

Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and design
by: Masayo Kojima, et al.
Published: (2022-12-01)

SUBCLINICAL INTERSTITIAL PULMONARY INJURY IN RHEUMATOID ARTHRITIS
by: D. V. Bestaev, et al.
Published: (2015-05-01)